News
-
12 March 2017
PanACEA kicks off new clinical trials programme for TB-drug evaluation
The EDCTP-funded PanACEA consortium (Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics) who were recently awarded their second EDCTP grant worth almost € 11.4 million (PanACEA2), held a kick-off meeting in Cape Town, South Africa from 7-8 March 2017.
-
18 January 2017
Call for PhD application
The IMPROVE Consortium seeks applicants for the following topics under 4 work packages
-
06 June 2016
KCRI staff meeting on Friday 3rd June,2016 at KCRI
-
13 April 2016
KCRI Strategic Plan (2016- 2026) review meeting
-
08 April 2016
VACANCY ANNOUNCEMENT: Lab Technologist
-
22 March 2016
Career Development Workshop from 16th to 17th and 21st March 2016 at KCMC
The workshop was funded by Wellcome Trust and Bills and Melinda Gates Foundation
-
22 February 2016
TWENDE Meeting at the Kilimanjaro Clinical Research Institute
-
04 February 2016
ZELS PROJECT MEETING -28th Jan - 3rd Feb 2016, KCRI
The meeting involved collaborators from Glasgow, KCRI and Nelson Mandela University
-
13 August 2015
Master of Science thesis defense 29th July 2015
KCRI/KCMU Co
-
13 April 2015
Prof. Dr. Martin Boeree presented MAMS TB 01 trial at CROI 2015
A combination regimen containing high-dose rifampicin (also known as rifampin) was associated with faster tuberculosis (TB) bacteria culture conversion in people with drug-sensitive TB, but moxifloxacin and the experimental drug SQ109 showed no benefit compared to standard therapy, according to results from a study presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA.
-
27 November 2014
GOOD CLINICAL PRACTICE TRAINING
- 1 of 7
- ››